January 01, 2024

LIVESTREAM Q + A

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Contact Lens Spectrum

October 01, 2023

AAO 2023 TO MEET IN SAN FRANCISCO

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Ophthalmology Management

October 07, 2024

Euretina 2024: Faricimab Shows Greater Hard Exudate Reduction Compared with Aflibercept

Faricimab’s dual inhibition mechanism led to a greater reduction in HE compared to aflibercept in DME patients.

Conexiant

September 19, 2024

Virtual Reality Treatment for Amblyopia Shows Clinically Meaningful Vision Improvement

The real-world data, presented at ARVO 2024

Conexiant

October 14, 2024

Euretina 2024: Voretigene Neparvovec-rzyl Therapy Long-Term Functional and Anatomical Outcomes

Patients experienced visual acuity gains in BCVA and full-field stimulus testing.

Conexiant

January 01, 2023

TrendSpotting

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Eyecare Business

September 01, 2023

#EBNewProducts: Retail Fashion

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Eyecare Business

December 01, 2023

THE GLOBAL SPECIALTY LENS SYMPOSIUM GUIDE

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Contact Lens Spectrum

October 14, 2024

p300 KAT Inhibitors Offer Potential Approach for Inflammatory and Autoimmune Conditions

The preclinical abstract will be presented at ACR Convergence 2024 in November.

Conexiant